EBUS-TNBA 22G samples: Comparison of PD-L1 expression between DAKO and BIOCARE ®

Conclusion: No statistical difference was observed between DAKO and BIOCARE®, therefore we propose that both techniques can be used in order to investigate the expression of programmed ligand 1 with safety. PD-L1 expression was higher in the central mass instead of the lymphnodes.

Source: Journal of Cancer - December 14, 2019 Category: Cancer & Oncology Authors: Konstantinos Sapalidis, Paul Zarogoulidis, Dimitris Petridis, Christoforos Kosmidis, Barbara Fyntanidou, Kosmas Tsakiridis, Elena Maragouli, Aikaterini Amaniti, Dimitris Giannakidis, Charilaos Koulouris, Stylianos Mantalobas, Athanasios Katsaounis, Vyron Tags: Research Paper Source Type: research